Drug
Gliclazide clinical trials
Also written Diamicron.
- studies test it
- 23
- open now
- 1
- in phase 3
- 0
- first study started
- 2004
Keep track of what changes. Save the Gliclazide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Development codes
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 4
- 12
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 16
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (3) · Weill Cornell Medical College in Qatar (1) · Zhibin Xu (1) · University of Sarajevo (1) · University of Dundee (1) · Merck KGaA, Darmstadt, Germany (1) · Seoul National University Bundang Hospital (1) · Merck Sharp & Dohme LLC (1)
Often tested with
Tested in the same studies.
Metformin (6) · Sitagliptin (3) · Liraglutide (2) · Dapagliflozin (2) · Insulin, Regular, Human (2) · Insulin (2) · Repaglinide (2) · Linagliptin (2)
Studies
Open first, then newest update. How each study uses Gliclazide is read from its arms, and is right about nine times in ten.
Testing it · 23
- Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM PatientsRecruitingNot applicableThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT06217887Written as Gliclazide Group
- HbA1c Variability in Type II DiabetesActive, not recruitingNot applicableWeill Cornell Medical College in QatarNCT02879409Written as Gliclazide
- Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical TrialCompletedNot applicableThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT06085703Written as Gliclazide
- Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With GlucotoxicityCompletedPhase 4Zhibin XuNCT06613750Written as Sitagliptin and Gliclazide
- Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetESStatus unknownPhase 4M.H.H. KramerNCT03433248Written as Gliclazide 30 mg QD/BID (N=22)
- Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid MetabolisersCompletedPhase 1University of SarajevoNCT04198948Written as Gliclazide
- Study of Sulphonylurea Synergy With IncretinsCompletedNot applicableUniversity of DundeeNCT03705195Written as Gliclazide
- Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy ParticipantsCompletedPhase 1Merck KGaA, Darmstadt, GermanyNCT03467945Written as Gliclazide
- Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideCompletedPhase 4Seoul National University Bundang HospitalNCT02610088Written as Gliclazide
- A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedPhase 4Merck Sharp & Dohme LLCNCT01709305Written as Gliclazide
- MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 DiabetesCompletedPhase 4Royal Devon and Exeter NHS Foundation TrustNCT01847144Written as Gliclazide 80mg OD
- Variation in Sulphonylurea Response in Type 2 DiabetesTerminatedPhase 4NHS TaysideNCT00738088Written as gliclazide
- Safety Evaluation of Adverse Reactions in DiabetesCompletedPhase 4Charles University, Czech RepublicNCT02092597Written as Gliclazide
- Antidiabetic Effects on Intrahepatic FatCompletedPhase 4The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT03068065Written as Gliclazide
- Bioequivalence Study of Gliclazide 120 mg Modified Release TabletsWithdrawnPhase 1Disphar International B.V.NCT02980757Written as Gliclazide 120 mg MR Tablets Formula A
- Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over StudyCompletedPhase 4Khoo Teck Puat HospitalNCT02201602Written as Gliclazide
- Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet FormulationsCompletedPhase 1Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories LimitedNCT02643329Written as BF-Gliclazide Tablet 80mg
- Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy VolunteersCompletedPhase 1Bial - Portela C S.A.NCT02777671Written as Gliclazide
- Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedPhase 4Novo Nordisk A/SNCT01022762Written as gliclazide
- The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 DiabetesCompletedNot applicableAnkara UniversityNCT01420692Written as Gliclazide MR
See all 23 studies that test Gliclazide →
Given in every arm · 1 — Gliclazide is usual care beside what is tested
As the comparator · 12 — what is tested is compared with Gliclazide
- Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.Not yet recruitingNot applicableYan BiNCT06222476Written as Gliclazide
- Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 DiabetesCompletedPhase 3Novartis PharmaceuticalsNCT00102466Written as Gliclazide
- Renoprotective Effects of Dapagliflozin in Type 2 DiabetesCompletedPhase 4M.H.H. KramerNCT02682563Written as Gliclazide 30mg QD
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.CompletedPhase 2University College DublinNCT01991197Written as Gliclazide
- Effect of Anti-diabetic Drugs on Glycemic VariabilityCompletedPhase 4Centro de Diabetes Curitiba LtdaNCT02925559Written as Gliclazide MR
- Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During RamadanCompletedPhase 4University of LeicesterNCT02694263Written as Gliclazide
- Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM PatientsStatus unknownPhase 3Sherief Abd-ElsalamNCT03313661Written as Gliclazide
- Response To Oral Agents in Diabetes (ROAD)- Pilot StudyCompletedPhase 4University of DundeeNCT00780715Written as Gliclazide MR
- Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 DiabetesCompletedPhase 3Novartis PharmaceuticalsNCT00102388Written as Gliclazide
- Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityCompletedPhase 4Centro de Diabetes Curitiba LtdaNCT01679899Written as Gliclazide MR
- Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During RamadanCompletedPhase 4Novartis PharmaceuticalsNCT01758380Written as Gliclazide
- Insulin Glargine in Type 2 Diabetic PatientsCompletedPhase 4SanofiNCT00347100Written as Glyclazide
Codes
What other systems call Gliclazide · ClinicalTrials.gg INT007554
- MeSH (NLM) D005907GliclazideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) G4PX8C4HKVGLICLAZIDEConfirmed FDA, NLM
- RxNorm 4816One source FDA
- NCI Thesaurus C87618GliclazideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005907 | Gliclazide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | G4PX8C4HKV | GLICLAZIDE | Confirmed FDA, NLM |
| RxNorm | 4816 | — | One source FDA |
| NCI Thesaurus | C87618 | Gliclazide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.